Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Philadelphia, PA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the...
-
Philadelphia, PA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute Hubert J.P. Schoemaker Education and Training Center can continue offering its signature Biomedical Technician Training (BTT)...
-
Philadelphia, PA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute announces the opening of its new Center for Advanced Therapeutics (CAT) to harness the power of Wistar science and speed...
-
Philadelphia, PA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- New research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in...
-
Philadelphia, PA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of...
-
Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute announces the National Institutes of Health (NIH) granted a five-year, $17 million research award to launch iCure Consortium...
-
Philadelphia, PA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious disease, announces the appointment of Simon...
-
Philadelphia, PA, March 21, 2025 (GLOBE NEWSWIRE) -- Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., in collaboration with scientists in the laboratory of Norbert Pardi, Ph.D., at...
-
PHILADELPHIA, PA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive brain cancers reprogram...
-
PHILADELPHIA, PA, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting...